These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 30238133)
1. Role of peroxisome proliferator-activated receptor alpha (PPARα) and PPARα-mediated species differences in triclosan-induced liver toxicity. Tang Y; M Vanlandingham M; Wu Y; Beland FA; Olson GR; Fang JL Arch Toxicol; 2018 Nov; 92(11):3391-3402. PubMed ID: 30238133 [TBL] [Abstract][Full Text] [Related]
2. Differential effects of triclosan on the activation of mouse and human peroxisome proliferator-activated receptor alpha. Wu Y; Wu Q; Beland FA; Ge P; Manjanatha MG; Fang JL Toxicol Lett; 2014 Nov; 231(1):17-28. PubMed ID: 25193434 [TBL] [Abstract][Full Text] [Related]
3. Investigation of the mechanism of triclosan induced mouse liver tumors. Wang Z; Li X; Klaunig JE Regul Toxicol Pharmacol; 2017 Jun; 86():137-147. PubMed ID: 28267557 [TBL] [Abstract][Full Text] [Related]
4. Chimeric mice with hepatocyte-humanized liver as an appropriate model to study human peroxisome proliferator-activated receptor-α. Tateno C; Yamamoto T; Utoh R; Yamasaki C; Ishida Y; Myoken Y; Oofusa K; Okada M; Tsutsui N; Yoshizato K Toxicol Pathol; 2015 Feb; 43(2):233-48. PubMed ID: 25107573 [TBL] [Abstract][Full Text] [Related]
5. Elevated basal expression of liver peroxisomal beta-oxidation enzymes and CYP4A microsomal fatty acid omega-hydroxylase in STAT5b(-/-) mice: cross-talk in vivo between peroxisome proliferator-activated receptor and signal transducer and activator of transcription signaling pathways. Zhou YC; Davey HW; McLachlan MJ; Xie T; Waxman DJ Toxicol Appl Pharmacol; 2002 Jul; 182(1):1-10. PubMed ID: 12127257 [TBL] [Abstract][Full Text] [Related]
6. Hepatic sirtuin 1 is dispensable for fibrate-induced peroxisome proliferator-activated receptor-α function in vivo. Bonzo JA; Brocker C; Jiang C; Wang RH; Deng CX; Gonzalez FJ Am J Physiol Endocrinol Metab; 2014 Apr; 306(7):E824-37. PubMed ID: 24496310 [TBL] [Abstract][Full Text] [Related]
8. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis. Yeldandi AV; Rao MS; Reddy JK Mutat Res; 2000 Mar; 448(2):159-77. PubMed ID: 10725470 [TBL] [Abstract][Full Text] [Related]
9. Role of the peroxisome proliferator-activated receptor alpha (PPARalpha) in responses to trichloroethylene and metabolites, trichloroacetate and dichloroacetate in mouse liver. Laughter AR; Dunn CS; Swanson CL; Howroyd P; Cattley RC; Corton JC Toxicology; 2004 Oct; 203(1-3):83-98. PubMed ID: 15363585 [TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor α agonist induces mouse hepatomegaly through the spatial hepatocyte enlargement and proliferation. Yang J; Yang X; Zhang YF; Tian JN; Fan SC; Gao Y; Li HL; Cai CH; Huang M; Bi HC Acta Pharmacol Sin; 2023 Oct; 44(10):2037-2047. PubMed ID: 37193756 [TBL] [Abstract][Full Text] [Related]
11. A species difference in the peroxisome proliferator-activated receptor α-dependent response to the developmental effects of perfluorooctanoic acid. Albrecht PP; Torsell NE; Krishnan P; Ehresman DJ; Frame SR; Chang SC; Butenhoff JL; Kennedy GL; Gonzalez FJ; Peters JM Toxicol Sci; 2013 Feb; 131(2):568-82. PubMed ID: 23143925 [TBL] [Abstract][Full Text] [Related]
12. Identification of novel peroxisome proliferator-activated receptor alpha (PPARalpha) target genes in mouse liver using cDNA microarray analysis. Cherkaoui-Malki M; Meyer K; Cao WQ; Latruffe N; Yeldandi AV; Rao MS; Bradfield CA; Reddy JK Gene Expr; 2001; 9(6):291-304. PubMed ID: 11764000 [TBL] [Abstract][Full Text] [Related]
13. Suppression of mouse hepatocyte apoptosis by peroxisome proliferators: role of PPARalpha and TNFalpha. Hasmall SC; James NH; Macdonald N; Gonzalez FJ; Peters JM; Roberts RA Mutat Res; 2000 Mar; 448(2):193-200. PubMed ID: 10725472 [TBL] [Abstract][Full Text] [Related]
14. Involvement of Peroxisome Proliferator-Activated Receptor-Alpha in Liver Tumor Production by Permethrin in the Female Mouse. Kondo M; Miyata K; Nagahori H; Sumida K; Osimitz TG; Cohen SM; Lake BG; Yamada T Toxicol Sci; 2019 Apr; 168(2):572-596. PubMed ID: 30629241 [TBL] [Abstract][Full Text] [Related]
15. The reversal of PXR or PPARα activation-induced hepatomegaly. Zhang Y; Yang J; Fan S; Gao Y; Cai C; Li H; Li X; Yang X; Xing Y; Huang M; Bi H Toxicol Lett; 2024 Jun; 397():79-88. PubMed ID: 38734220 [TBL] [Abstract][Full Text] [Related]
16. Disruption of hepatic lipid homeostasis in mice after amiodarone treatment is associated with peroxisome proliferator-activated receptor-alpha target gene activation. McCarthy TC; Pollak PT; Hanniman EA; Sinal CJ J Pharmacol Exp Ther; 2004 Dec; 311(3):864-73. PubMed ID: 15265979 [TBL] [Abstract][Full Text] [Related]
17. 2,3,5,4'-tetrahydroxy-stilbene-2-O-β-D-glucoside promotes liver regeneration after partial hepatectomy in mice: The potential involvement of PPARα-mediated fatty acid metabolism. Xue H; Nie H; Huang Z; Lu B; Wei M; Xu H; Ji L J Ethnopharmacol; 2024 Nov; 334():118513. PubMed ID: 38969151 [TBL] [Abstract][Full Text] [Related]